Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
about
Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells.Oblimersen for the treatment of patients with chronic lymphocytic leukemia.EBNA1 regulates cellular gene expression by binding cellular promotersBcl2 is not required for the development and maintenance of leukemia stem cells in mice.An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.Bcl-2 level as a biomarker for 13q14 deletion in CLL.5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cellsKaryotypic and molecular abnormalities in chronic lymphocytic leukaemiaUpregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.Comparison of Bcl-2, CD38 and ZAP-70 Expression in Chronic Lymphocytic Leukemia.Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells.H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.Targeting Mitochondrial Ion Channels to Fight Cancer
P2860
Q30361951-B12C6D9E-AD9A-4516-BD68-AB0BAEC04D22Q33379565-18A19821-1BE4-4DF5-8F47-F642CB6A94F7Q33563969-0217B845-4683-41CF-96F1-FF949A079EA9Q33947776-9474DED6-2712-4751-A0C9-DFC8BC8D02B4Q36650527-2431E949-E8BC-4994-BAB5-3DAACAB0DD85Q37268297-30C24D85-228A-4948-9C1D-8D0A7F16673EQ37657896-4A6BFBB9-373B-4037-90B7-8997EDB27398Q37659067-F15B452F-D6CE-47D6-9E81-0D46035B6068Q39433259-F3ECCE1B-1FD3-4DD3-9C24-FAF0E9061DE6Q40849418-BE359086-38DE-4417-91BC-272D04780840Q41447311-2FA2CDB3-A038-467B-8178-2F6B7CE55D62Q42134533-70AFD3F5-ED01-4530-8D26-53A1525DE5C1Q42638970-5DE7D0C9-75A1-4EC5-BF0D-FAA006D4B689Q42942120-61BB9A4B-E4F6-4A85-9EB8-7B6E8FF6B295Q53477055-F4DF6BCA-D010-4FE7-815D-8CDF4D7E4191Q57175954-851CC805-A464-4D7F-887E-6B742C0B658E
P2860
Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@en
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@nl
type
label
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@en
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@nl
prefLabel
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@en
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@nl
P2093
P1433
P1476
Growth- and differentiation-as ...... ic lymphocytic leukemia cells.
@en
P2093
Caligaris-Cappio F
Carlsson M
Gottardi D
Larsson LG
P304
P407
P577
1992-06-01T00:00:00Z